Product Images Bupropion Hydrochloride (sr)

Each extended-release tablet contains 100 mg of bupropion HCI, which is manufactured by Wockhardt Limited in Mumbai, India. The medication is labelled with the trademark name ZYBAN, and the pharmacists must provide enclosed Medication Guide to each patient. The medication should not be used with any other medicines containing bupropion hydrochloride. The package insert should be referred for full dosage information, and the medication should store at a temperature of 20°-25°C (68°-77°F).*

This is a medication description for bupropion HCI extended-release tablets containing 150mg. It is recommended that patients receive a medication guide and dosage information from their pharmacist. It should be stored at 20°-25°C (68°-77°F). It is important not to use this medication in combination with ZYBAN or other medications containing bupropion hydrochloride. This medication is manufactured and distributed by Wockhardt USA LLC, and contains 60 tablets.*

This text is a medication label for a drug called Bupropion HCI, with NDC code 64679-107-03. Each tablet contains 200mg Bupropion HCI and needs to be taken twice daily after initial titration. The medication comes in extended-release tablets and should be dispensed with a medication guide to each patient. The drug should not be used in combination with other medications containing Bupropion hydrochloride. The medication should be stored between 20°-25°C (68°-77°F). The text also provides information about the manufacturer, GlaxoSmithKline, and the number of tablets, which is 100.*